Applications are now open for Year 2 of Grow-NY, the food and agriculture business competition administered by Cornell's Center for Regional Economic Advancement and funded by Empire State Development.
Students in the Samuel Curtis Johnson Graduate School of Management have found fun, interesting and valuable ways to make the most of physical distancing by creating new ways to engage.
Mathematical modeling by Weill Cornell Medicine is helping to guide New York state and New York City leaders as they make decisions that could affect the trajectory of the COVID-19 pandemic.
Cornell University has made a $100,000 contribution to help establish a Tompkins County/City of Ithaca COVID-19 Small Business Resiliency Fund to support and stabilize local small businesses impacted by the coronavirus pandemic.
A free weekly research webinar series organized by a Cornell faculty member has more than 1,000 viewers – with more expected – and is quenching a thirst for science and interaction felt by researchers around the world.
With lives and livelihoods on pause due to COVID-19, Cornell’s Institute of Politics and Global Affairs hosted a TeleTown Hall April 8 to explore a potential timeline for treatment.
A new study identifies some of the most critical genes that may drive a rare but deadly liver cancer, providing a road map for developing drugs that target those genes.
A Cornell researcher has created a tool to track the algorithms on Reddit, to inform people how the site is deciding which coronavirus-related posts to recommend to its hundreds of millions of users.
A 4-year-old tiger at the Bronx Zoo tested positive for COVID-19 on April 5, the diagnosis confirmed thanks in part to an assist from Cornell’s Animal Health Diagnostic Center.
As hospitals and emergency departments urge more patients to stay home to avoid exposing themselves to COVID-19, patient care is moving to “telemedicine,” using web-based video and audio technology.
The Cornell NanoScale Science and Technology Facility enables scientists and engineers from academia and industry to conduct micro- and nanoscale research with state-of-the-art technology and expertise from its technical staff. But perhaps the facility’s greatest breakthrough is helping launch startup companies in New York state.